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Thesis Abstract 
 
Turkish Standardization of the Symptom Assessment-45  
Questionnaire (SA-45) 
Hejan  Epözdemir 
 
 
The purpose of this study is to conduct standardization of Symptom 
Assessment-45 Questionnaire (SA-45) including reliability and validity 
analyses and a norm study for Turkish adult population. 
In the present study two different samples, which included non-
clinical and outpatient samples were used. The non-clinical sample included 
620 adult individuals 520 of whom were working as professionals in 
companies and the other 100 were psychology students at Istanbul Bilgi 
University. The outpatient sample of this study was 2481 individuals who 
had applied to the Institute for Behavioral Studies (DBE) for psychotherapy.   
The psychometric analyses of SA-45 were conducted in three steps. 
First, the norm study of SA-45 scales was performed for the non-clinical 
sample by gender. Second, the reliability analyses were conducted for both 
non-clinical and outpatient sample. And finally, the validity analyses were 
performed for both non-clinical and outpatient samples.  
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Overall the results of the reliability and validity analyses and the 
norm study of the present study are discussed in comparison with the results 
of the original study. Consequently the results of the current study 
demonstrated that SA-45 was a valid and reliable instrument for Turkish 
adult population and that it could be used for several clinical purposes such 
as helping diagnose, planning treatment, monitoring, and therapy outcome 
assessment. However, further studies are needed with inpatient samples for 
completing Turkish standardization of Symptom Assessment-45 
Questionnaire (SA-45). 
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Tez Özeti 
 
Semptom Değerlendirme Ölçeği’nin (SA-45) Türkçe Standardizasyonu 
Hejan Epözdemir 
 
 
Bu çalışmanın amacı, Semptom Değerlendirme Ölçeği’nin (SA-45) 
Türk yetişkin nüfusu için geçerlik, güvenirlik analizleri ile norm çalışmasını 
içeren standardizasyon çalışmasını yapmaktır. 
Bu çalışmada normal ve ayakta tedavi gören olmak üzere iki farklı 
örneklem grubu kullanılmıştır. Normal örneklem grubu şirketlerde çalışan 
520 profesyonelden ve Đstanbul Bilgi Üniversitesi Psikoloji Bölümü’nde 
okuyan 100 öğrenci olmak üzere toplam 620 kişiden oluşmaktadır. Ayakta 
tedavi gören diğer grup ise, Davranış Bilimleri Enstitüsü’ne (DBE) 
psikoterapi için başvuran 2481 kişiden oluşmaktadır.  
SA-45’in psikometrik analizleri üç aşamada gerçekleştirilmiştir. Đlk 
olarak normal grup ele alınmış ve cinsiyete göre norm çalışması yapılmıştır. 
Đkinci aşamada hem normal hem de ayakta tedavi gören grup için ayrı ayrı 
güvenirlik analizleri, üçüncü aşamada ise yine her iki grup için geçerlik 
analizleri tamamlanmıştır. 
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Bu çalışmada güvenirlik ve geçerlik analizlerinin ve norm 
çalışmasının sonuçları, orijinal çalışmanın sonuçları ile karşılaştırılarak 
tartışılmıştır. Sonuçlar, SA-45’in Türk yetişkin nüfusu için geçerli ve 
güvenilir bir ölçme aracı olduğunu ve tanı, tedavi planı, izleme ve terapi 
sonuçlarını değerlendirme gibi klinik faaliyetlerde yardımcı bir araç olarak 
kullanılabileceğini göstermektedir. Buna karşın, Semptom Değerlendirme 
Ölçeği’nin (SA-45) Türkçe standardizasyon çalışmasının tamamlanması 
için, yatarak tedavi gören hastalarla yapılacak çalışmalara ihtiyaç vardır.  
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Chapter 1: Introduction 
 
1.1 Purpose of the Study 
The purpose of this study is to conduct standardization of Symptom 
Assessment-45 Questionnaire (SA-45) including reliability, validity 
analyses and norm study for the adult Turkish population.  
 
1.2 Psychological Assessment 
The term “psychological assessment” is very often used almost 
synonymously with ‘psychological testing’. Although psychological 
assessment includes psychological testing, it covers many  more activities 
than psychological testing (Groth-Marnat, 2003; Matarazzo, 1990). At this 
point, Maloney and Ward (1976, p.5) has stated: “Psychological assessment 
is an extremely complex process of solving problems (answering questions) 
in which psychological tests are often used as one of the methods of 
collecting relevant data”   
Psychological assessment involves clinical interviews, natural 
behavioral observations, review of historical documents and collateral 
reports, and interpretation of test results (Groth-Marnat, 2003; Matarazzo, 
1992). Consequently in the Handbook of Standards for Educational and 
Psychological Testing, psychological assessment is defined as (AERA, 
APA, & NCME, 1999, p. 119): 
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 “A psychological assessment is a comprehensive examination 
undertaken to answer specific questions about a client’s 
psychological functioning during a particular time interval or to 
predict a client’s psychological functioning in the future”.  
 
Psychological assessment is very important for the description of 
normal and abnormal behavior. Specifically, it is functional in 
understanding and evaluating of personality and problems of individuals in 
various domains of life.  
             This means that psychological assessment is very important in 
diagnosing psychological and psychiatric problems and planning treatment. 
When a clinician is in doubt about the diagnosis of a client, it can be helpful 
to examine the client to ascertain the diagnoses by psychological 
assessment. This may happen rather frequently because there are numerous 
occasions where clients have many problems which lead to multiple 
diagnoses or when a disorder is masked by symptoms of a totally different 
disorder. Particularly if a clinician suspects that a client is prone to suicide 
or homicide, the clinician will need more information about the client, 
therefore psychological assessment will be necessary to examine the client’s 
risk behaviors and emotional or mental status. Not only to examine risky 
behaviors or emotional disturbances, but also for other purposes evaluation 
of a patient’s cognitive and emotional status or person’s abilities and skills.  
Also in a typical interview a clinician gathers information about the client’s 
past but that may never be complete because of time restriction imposed by 
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a session. So it may be helpful to gather extensive information in a short 
time about a client by a psychological assessment (Groth-Marnat, 1999 & 
2000; Olin & Keatinge, 1998).  
             On the other hand, the therapist may be comfortable with the 
diagnosis but may not be clear about the kind of therapy that is required. 
Clinical assessment generally identifies weaknesses and strengths of the 
client so that the clinician can make critical decisions about how the therapy 
will be conducted. Among others, these may involve deciding what kind of 
therapy is appropriate, crisis intervention, hospitalization, child custody and 
medication. Consequently, psychological assessment may be used for 
diagnosing, therapy planning, career adjustments or planning a training 
program for the client (Groth-Marnat, 1999 & 2000; Olin & Keatinge, 
1998).  
At this point, as mentioned above briefly, one has to make a 
distinction between testing and assessment. By using a test in an assessment 
a clinician obtains partial information that he or she can obtain from a whole 
assessment. Generally many instruments are used, which may include 
several tests measuring a range of states, from mental disorders to a variety 
of skills, and the whole information is put together in the course of an 
assessment. In an assessment the major concern is to determine what the 
diagnosis is, to resolve to what extent the client is able to function, in order 
to plan the therapy and measure outcome of the therapy (Anastasi, 1982; 
Olin & Keatinge, 1998).  
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           Actually, when the literature is examined, it can be seen that the 
histories of psychological assessment and testing were overlapping. But 
today, as mentioned above, the meaning of assessment has been expanded. 
Consequently, in the following paragraphs, the history of psychological 
assessment and psychological testing are presented separately.  
 
1.2.1 The History of Psychological Assessment 
The earliest form of psychological assessment was the clinical 
interview. For instance, clinicians such as Freud and Jung used unstructured 
clinical interviews in order to get information about their patients for 
diagnosis and understanding the structure of personality. However, some 
clinicians have stated that these unstructured clinical interviews were not 
reliable and valid empirically (Groth-Marnat, 2003; Jensen-Doss & Weisz, 
2008).  
Realizing that there is a strong need for psychometrically sound 
instruments, several pioneers have worked to develop them. Throughout 
1920s to 1960s, authors have produced varieties of psychological 
assessment tools (Groth-Marnat, 2003; Matarazzo, 1990).  
During the 1960s and 1970s many tests were designed to eliminate 
subjectivity and bias of the interview techniques. Indubitably, the increase 
in popularity of behavior therapy contributed to development of more 
quantitative, structured and formalized methods of behavioral and 
psychological assessment over the years. Advance in the development of 
more structured tests is probably due to a general dissatisfaction with the 
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Diagnostic and Statistical Manual of Mental Disorders (DSM; American 
Psychiatric Association, 1952)  and requirement for instruments to measure 
the therapy process and therapy outcome (Groth-Marnat, 2003; Matarazzo, 
1990).  
During the 1980s and 1990s, a wide variety of structured interview 
methods were developed and gained popularity such as Diagnostic 
Interview Schedule (DIS; Robins, Helzer, Cottler & Goldring, 1989), 
Structured Clinical Interview for DSM (SCID; Spitzer, Williams & Gibbon, 
1987) and Renard Diagnostic Interview (RDI; Helzer, Robins, Croughan & 
Welner, 1981). These instruments, which were very different from 
unstructured interviews, had more advantages psychometrically. So, they 
were preferable to unstructured interviews.  
Also in the early 1900s administration of self-report personality 
instruments progressed, specifically during World War I. They were used 
for screening the pathology of men who were about to enter the military 
service. For example, the Personal Data Sheet which was developed by 
Woodworth was used for this purpose (Anastasi, 1982; DuBois, 1970; 
Franz, 1919; Groth-Marnat, 2003). Since that time, a lot of psychological 
instruments were developed which included the clinical personality tests 
such as Rorschach, Thematic Apperception Test (TAT), Minnesota 
Multiphasic Personality Inventory (MMPI), aptitude and achievement tests 
such as Stanford Achievement Tests (SAT), Primary Mental Abilities Tests 
(PMAT), neuropsychological and intelligence tests such as Wechsler Adult 
Intelligence Test (WAIS), Luria and Halstead-Reitan Batteries and 
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industrial tests measuring leadership and management skills and tools for 
assessing performance by assessment centers, 360 degree and employee 
satisfaction  scales and others  (Matarazzo, 1990, 1992)  
 During recent years, traditional means of assessment have expanded 
to include a wide variety of techniques such as psychological tests and 
inventories, naturalistic observations, neuropsychological assessment, and 
behavioral assessments (Groth-Marnat, 2000 & 2003). Among these, the 
psychological tests and inventories are the most standardized and reliable 
measurement instruments. 
 
1.2.2 Brief History of Psychological Testing 
“A psychological test is essentially an objective and standardized 
measure of a sample of behavior” (Anastasi, 1982, p.22). This definition of 
the psychological tests has 3 important characteristics which emphasize a 
more reliable measurement than other assessment methods: A psychological 
test is a sample of behavior which is obtained under standardized conditions 
and there are established rules for scoring or for obtaining quantitative 
information from the behavior sample (Murphy & Davidshofer, 1991).  
Cronbach (1970) stated four functions and objectives of 
psychological tests. According to him the first function of psychological 
tests is the sampling of behaviors. Tests isolate and use samples of behavior, 
which give us the scores on a test, so that one can make generalizations 
about an individual. The second function of psychological tests is 
categorizing individuals. This function of psychological tests is used 
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frequently by clinicians or researchers in routine clinical practice. Often the 
clinician needs to diagnose psychiatric problems to be able to decide on the 
type of therapy or medication. The third function of psychological tests is 
evaluating and comparing therapy methods. The researcher and the clinician 
need to know which approach or what kind of therapy is effective for a 
particular problem area. And lastly according to Cronbach (1970), 
psychological tests enable the researcher or the clinician to test hypotheses 
in research (Cronbach, 1970).      
 The use of the psychological tests dates back to the 1800s. Cattell’s 
(1890) “mental test” is accepted as the first psychological test. Following 
him, the first formal psychological test was developed by Binet (1904) 
which measured the intelligence level of children so that they could be 
placed in classes appropriately by the commission of French Ministry of 
Public Instruction. Subsequently in 1905 he created the Binet-Simon 
Intelligence Test which was revised by Terman in 1916 and is known as 
“Stanford-Binet Intelligence Test” today. After Binet’s intelligence test 
many researchers were interested in psychological tests (as cited in Gould, 
1981).  
As mentioned above, development of psychological tests, 
particularly personality and mental tests was speeded up during World War 
I and then II by the need to recruit army cadets and employ them in proper 
roles. Since then many personality instruments have been developed to 
measure psychopathology, mental disorders and many other psychological 
problems. At present the most widely used and most comprehensive one is 
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Minnesota Multiphasic Personality Inventory (MMPI) and the latest version 
(MMPI-2) (Geisinger, 2000; Matarozza, 1990).    
   Beginning from 1935, the relative popularity of psychological 
tests  increased by being used in different contexts like university clinics, 
psychiatric units, psychological treatment centers, VA Hospitals, centers for 
developmentally disabled, private practice, and professional organizations. 
Later this led many researchers to demand from test authors to develop 
instruments to evaluate interventions and therapy outcome and this further 
increased the development and use of psychological tests (Groth-Marmat, 
2003). So today, psychological tests are used in various areas of applied 
psychology such as clinical, counseling, and industrial and school 
psychology. Among these, in clinical psychology, they are used frequently 
for purposes such as assessment of intelligence, personality, 
psychopathology (abnormal behavior, emotional disturbance etc.).  
The clinical use of psychological testing generally serves two 
purposes: diagnosing and planning treatment. Furthermore, psychological 
tests are also important for development and evaluation of research-based 
assessment and intervention, such as therapy outcome research or public 
mental health program evaluation in clinical psychology (Anastasi, 1982; 
Murphy & Davidshofer, 1991).  
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1.2.3 Criticisms of the Use of Psychological Tests in Clinical 
Assessment  
Although the use of tests and inventories in routine clinical practice 
for psychological assessment and other purpose is becoming more and more 
prevalent all around the world, using tests for diagnostic and clinical 
decisions has been criticized. One criticism comes from psychoanalytic 
theory. Psychoanalytic theory asserts that there is no qualitative distinction 
between pathology and normality. Therefore they do not view pathology as 
illness categorically different from normality. This is one reason why they 
have always been reluctant to measure pathology and try to avoid using 
diagnostic tests and inventories derived by using quantitative methods 
(Bowers, 2000; Hortwitz, 2002). When one examines the testing literature, 
one can see that some authors have designed tests with a clear aim of 
categorizing individuals. On the other hand the current tendency is that the 
tests are based on norms and continuous scores. This allows the clinician to 
examine the results on a continuum rather than categorically. Although this 
is the case, many psychoanalytic theoreticians, holding on to their 
theoretical positions, still today criticize psychological tests, not taking into 
account the strong demand from the mental health sector on the mental 
health provider, namely screening and/or diagnosing clients.     
Another rather radical criticism comes from the “social 
constructionist” view. They assert that diagnostic language which includes 
“mental illness and disease” is manufactured culturally and it is a meaning 
giving activity. Therefore illness, pathology, and disease are concepts and 
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do not reflect an entity in physical reality.  They think of psychiatry as a 
game in power politics. Pathology and normal behavior are determined by 
the rules working in that specific society. Thinking along these lines, social 
constructionists are opposed to diagnostic approaches and as a logical 
extension, to measuring “mental illness” (Bowers, 2000; Hortwitz, 2002). 
Although the richness of human condition cannot be expressed in a well 
defined language, the diagnostic approach enables the clinician to describe 
and define the problem and help planning the treatment. Moreover, 
psychological tests generally are used for evaluating the individuals in 
various domains, which include emotional disturbance, cognitive 
functioning, attitudes, abilities, behaviors and help in diagnosing and 
planning treatment, but they are not sufficient for a full diagnosis by 
themselves. So for a full diagnosis, apart from assessing the individual 
psychologically and using tests, the clinician has to use some other tools 
such as natural observations, clinical interviews. One may conclude that 
psychological tests are very helpful tools for the clinician in screening the 
symptoms and formulating the diagnosis and the treatment plan.  
And the last criticism is that testing has not shown improvement and 
innovation after the first examples. This applies to both personality and 
ability tests in the market. In any other industry and sector, this has proved 
to be the opposite (Meier, 2008). Sternberg and Williams (1998) point out 
that the reason why test publishers do not innovate is that, in other sectors if 
you do not create new products you cannot survive, whereas, in the testing 
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industry, the tests that have been produced in the last century are variations 
on the same theme.  
All in all, it can be asserted that psychological tests, on one hand, are 
not sufficient to diagnose abnormal behavior on their own. However, on the 
other hand, they provide the clinician the opportunity to make an evaluation 
based on psychometric data and hence, enlarge his or her clinical 
perspective. So testing allows the clinician to evaluate the individuals’ 
behavior, personality, intelligence or emotional disturbance and therefore 
contribute to clinical observation and diagnosis.    
Consequently psychological tests can be used in clinical practice and 
psychological research as contributory. At this point, selecting the most 
applicable test becomes important for researchers or routine clinical 
practice. Derogatis and Spencer (1982) mentioned the benefits of self-report 
instruments. Derogatis and Spencer (as cited in SAI, 2000, p.2) indicated 
that “….self-report instruments elicit information that is not available even 
to trained observers of human behavior; namely, information about internal 
phenomena that can be only be inferred by mental health professionals from 
an individual’s behavior”.  They also pointed out the economic benefits of 
using self-report instruments which do not require the time and expense of 
clinicians for administration and sometimes also for scoring. Additionally, 
they emphasized that the tests are psychometrically objective and powerful.   
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Despite the fact that self-report instruments have their own benefits 
they have some limitations. The most significant limitation is the excessive 
length of many of these instruments. This is the case especially for 
multidimensional, multi-scale instruments such as MMPI and others. In 
addition, multidimensional inventories take a long time for the clinician to 
administer and to calculate the score. According to Maruish (2004, p. 43): 
 
 
“The form of assessment commonly used is moving away from 
lengthy, multidimensional objective instruments (e.g. MMPI) or 
time-consuming projective techniques (e.g., Rorschach) that 
previously represented the standard in practice. The type of 
assessment authorized now usually involves the use of brief, 
inexpensive, yet well-validated problem-oriented instruments. This 
reflects modern behavioral health care’s time-limited, problem-
oriented approach to treatment. Today, the clinician can no longer 
afford to spend a great deal of time in assessment when the patient is 
only allowed a limited number of payer-authorized sessions. Thus, 
brief instruments will become more commonly employed for problem 
identification, progress monitoring, and outcomes assessment in the 
foreseeable future” 
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1.3 Symptom Assessment-45 Questionnaire (SA-45)  
1.3.1 History of Symptom Assessment-45 Questionnaire (SA-45)  
Derogatis and Spencer (1982) stated that there is a need for a simple, 
short, easily administered and scored, comprehensive general self-report 
measure of psychological distress. Having this in mind, Derogatis and his 
team began with the Hopkins Symptom Checklist (HSCL; Derogatis, 
Lipman, Rickels, Uhlenhuth, & Covi, 1974a, 1974b) and later developed a 
group of short tests.  However the HSCL had some practical shortcomings 
and this led to the development of Symptom Checklist-90 (SCL-90; 
Derogatis, Lipman, & Covi, 1973) which was later revised and published as 
the Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 1983, 1994; 
Derogatis, Rickels, & Rock, 1976). SCL-90-R includes 90 items and 
measures psychological symptoms and distress regarding 9 psychiatric 
symptom domains which are somatization, obsessive compulsive symptoms, 
interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, 
paranoid ideation, and psychoticism and 3 global indices; GSI (Global 
Severity Index), PST (Positive Symptom Total), and PSDI (Positive 
Symptom Distress Index) (Derogatis, 1983, 1994; Derogatis, Rickels, & 
Rock, 1976). 
Derogatis and his team developed the Hopkins Psychiatric Rating 
scale (HPRS)-the SCL-90 Analogue Scale and Brief Symptom Inventory 
(BSI; Derogatis, 1975). Brief Symptom Inventory (BSI) was the short form 
of SCL-90 which included 53 items and 9 subscales and 3 global indices 
like SCL-90 (Derogatis, 1975, 1992, 1993). So according to them, there still 
14 
 
was a need for an instrument that cost very little, and that could be used for 
screening purposes, as a research tool and therapy outcome. Strategic 
Advantage, Inc. (SAI, 2000) specializing in measuring therapy outcome, 
decided to shorten the SCL-90 by using its items.  
Derogatis’s extensive work with the SCL-90 (Derogatis & Cleary, 
1977) had clearly shown that for the scales a small number of items were 
sufficient to keep the construct valid. Also SAI had used the SCL-90 as an 
outcome measure for many years and knew that it worked for that purpose. 
The size of the sample that the SCL-90 used was very large and that 
justified using the data for developing a new instrument.  
Therefore the 45 “best” items were selected and they formed the 
basis of the Symptom Assessment-45 Questionnaire (see Appendix A). 
Norms for both adolescents and adults were developed by using inpatient 
and non-patient populations. Validity and reliability studies were done using 
those data (SAI, 2000).  
Symptom Assessment-45 Questionnaire (SA-45) was developed 
with the idea of a fairly short, psychometrically sound and acceptable 
instrument to measure psychiatric symptoms and that could be used for 
measuring therapy outcome. SA-45 was also designed to screen clients for 
several purposes and to measure therapy progress (Maruish, 2004). 
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Table 1 
Brief Description of SA-45 Subscales and Indices 
Subscales and Indices                                                          Description 
 
 
Subscales 
 
 
 
Anxiety (ANX) 
Anxiety scale contains items which try to capture behaviors related to 
fear, feelings of panic and tension.  
Depression (DEP) 
 
Depression Scale measures feelings of loneliness, hopelessness, 
worthlessness and loss of interest. 
Hostility (HOS) 
 
This scale consists of behaviors like outbursts, arguing a lot, shouting, 
breaking things and intense need to harm people 
Interpersonal Sensitivity (INT) 
 
This scale inquires about how one feels about him/herself in relation to 
others. The items measure feelings of devaluation, feelings that people are 
not friendly and feeling distress when talking to people or when being 
watched.  
Obsessive-Compulsive (OC) 
 
The items of this scale consist of symptoms related to lack of 
concentration and difficulties around deciding things such as checking 
behavior, doing things slowly in order to be correct and feeling that the 
mind is empty. 
Paranoid Ideation (PAR) 
 
Rather than containing clear paranoid symptoms, the items of this scale 
inquire about behavior that is indicative of paranoid thinking. They 
include feelings that people cannot be trusted and that they are the cause 
of “my problems”, that they talk about him in a negative way and that the 
person gets negative feedback frequently for his\her behavior.  
Phobic Anxiety (PHO) 
 
This scale consists of items asking about feelings of fear and distress 
when people are in open spaces and crowds, in traffic, and going out 
alone. Avoiding situations, stimuli and behavior is also inquired. 
Psychoticism (PSY) 
 
This scale concentrates on problems related to dysfunctional thinking 
patterns. The items include auditory hallucinations, thoughts about people 
controlling one’s mind and thinking that one is guilty and has to be 
punished.  
Somatization (SOM) 
 
The items of this scale consist of rather subtle bodily experiences like 
numbness, feeling hot or cold, tingling, heaviness in body organs.    
  
Indices  
  
Global Severity Index (GSI)  
GSI gives the total value, as marked from 1 to 5 for each item, for all the 
items of SA-45.  
Positive Symptom Total (PST) 
 
PST gives the total number of symptoms that the respondent checked as 
present which includes items yielding a response other than “Not at all”.  
Note: Adapted from Symptom Assessment-45 Questionnaire (SA-45): Technical Manual (p.1), by Strategic Advantages Inc., 
2000.  
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1.3.2 Descriptive Information about SA-45  
Symptom Assessment-45 Questionnaire (SA-45) consists of 45 items 
and measures 9 psychiatric symptom domains which are somatization, 
obsessive compulsive symptoms, interpersonal sensitivity, depression, 
anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. In 
addition to these subscales, it includes 2 index scores: General Severity 
Index (GSI), and Positive Symptom Total (PST).  The items are rated on a 
5-point scale which ranges from “not at all” to “extremely” (SAI, 2000) (see 
Table I for information about subscales of SA-45). 
Although SA-45 does not present a definite and illustrative clinical 
picture by itself, it has several important advantages for screening 
symptoms, helping diagnose, planning treatment, and measure clinical 
progress and outcome. First, it is the short form of SCL-90-R which is one 
of the most widely used self-report instruments in clinical psychology 
(Groth-Marnat, 2003) and it is a reliable and valid self-report instrument 
(Derogatis, 1983). Second, SA-45 is as psychometrically powerful, reliable, 
and valid as the SCL-90. Third, it is short and easily administered (about 10 
minutes) and scored. Fourth, it can be used in any kind of setting where it is 
needed, such as inpatient, outpatient and primary care facilities. And last, it 
can easily be used with groups, specifically for screening problematic 
individuals in large groups in a short time such as public mental health 
assessment and research. So these are the advantages of SA-45 which make 
it possible to evaluate the individuals in a relatively short time in routine 
clinical practice (SAI, 2000). 
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In the next paragraphs, psychometric studies and characteristic of 
Symptom Assessment-45 Questionnaire (SA-45) are reported. Firstly the 
development process of SA-45 which includes selection of items and 
characteristics of samples separately for both inpatient and non-clinical 
samples by gender is explained. After that, in the following subsections the 
reliability and validity analyses and norm study of SA-45 are described.  
 
1.3.3 Development, Reliability and Validity of SA-45 
The psychometric studies of SA-45 were executed by using “non-
clinical” and “inpatient” samples. In the following subsections, the 
psychometric studies of SA-45 are presented which include the development 
process, reliability and validity analyses respectively.   
 
1.3.3.1 Development of SA-45 
The process of development of SA-45 was completed in three steps 
which included the item selection and constitution of the subscales, 
calculation of norms and comparison of the results of non-clinical sample 
with a large inpatient sample. At the beginning the items of SA-45 were 
taken from SCL-90 results where the inpatients of private psychiatric 
hospitals filled out SCL-90 while being admitted to the hospital. This 
“development sample” was composed of inpatients consisting of 690 adult 
females, 829 adult males, 466 adolescent females, and 400 adolescent males 
(Davison, Bershadsky, Bieber, Silversmith, Maruish & Kane, 1997).   
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Selecting the items of SA-45 was the initial step which finally 
indicated to the structure of symptom domains. In order to achieve this, item 
correlations were obtained and as a method “cluster analysis” was applied 
by utilizing the correlational matrix. Initially, every single item was 
assumed to be a unique cluster of its own. As a first step, the two items that 
had the highest correlation were brought together to form a cluster. In every 
subsequent step, the two most similar clusters were brought together. 
Similarity in this case meant the average correlation between the items of 
the two clusters. As a result, nine scales corresponding to the subscales of 
SCL-90 were formed, where each subscale involved those five items that 
the corresponding scale of the SCL-90 contained. The subscales of the 
parent SCL-90 had also been obtained by cluster analysis (Davison, 
Bershadsky, Bieber, Silversmith, Maruish & Kane, 1997). 
After the items were chosen and the sub-scales of SA-45 were 
established, a sample from the “normal population” was used to arrive at 
the norms. This “non-clinical sample” was comprised of employees of an 
HMO (Health Maintenance Organization) and their families, high school 
students which included 748 adult females, 328 adult males, 321 adolescent 
females and 293 adolescent males for SCL-90. For the norm study, the 
mean and standard deviations of each SA-45 subscale, percentiles and T 
scores which were derived to mean of 50 and a standard deviation of 10 
were calculated for both adults and adolescents by gender and cutoff points 
established for clinical decisions. In accordance with this, T scores of 60 or 
higher are accepted as a cutoff point indicating a possible clinical 
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significance which requires further investigation. Furthermore, a T score of 
65 or 70 is accepted as the criterion, score for non referred individuals who 
were not identified as having psychological problems (Maruish, 2004; SAI, 
2000). 
As a last step, the idea was to compare the results of SA-45 from 
large non-clinical sample with a large “comparison data”. One may further 
speculate that if the clinician is able to compare the applicant with the 
inpatients, he or she will be in a stronger position to make more sound and 
valid judgment about a client’s responses. For this reason, the results 
obtained from adult and adolescent inpatients who filled out the SCL-90 
were re-scored to be able to obtain scores for each of the SA-45 subscales 
and indices. This sample was comprised of 5,317 adult females, 5,834 adult 
males, 2,889 adolescent females, and 2,331 adolescent males who were 
administered the SCL-90 at the time of admission to inpatient facilities for 
behavioral health treatment. Consequently, percentiles and T scores were 
calculated for inpatient adults and adolescents according to the gender 
(Maruish, 2004; SAI, 2000). 
 
1.3.3.2 Reliability Analyses of SA-45 
For the reliability analysis of SA-45, internal consistency, test-retest 
correlations and SEM scores were calculated.    
The Cronbach’s alpha correlation coefficients of the 9 subscales of 
SA-45 Questionnaire were between .71 and .91 and they were derived from 
the non-clinical and inpatient samples separately for both adult and 
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adolescents (see Table 2 for Cronbach’s alpha correlation coefficients of the 
subscales of SA-45). The results indicated that the internal consistency of 
SA-45 Questionnaire scales is psychometrically sound and reliable (SAI, 
2000).  
For the non-clinical adult sample test-retest correlations were 
between .42 and .88. The results of the non-clinical adolescent sample 
correlations ranged from .58 to .85. For inpatients, both adult and adolescent 
samples, test-retest correlations were done in 1, 2, and 3-week intervals. 
One week interval test-retest correlations for adults were between .42 and 
.59 and between .46 and .53 for adolescents. Basically these correlations 
were within the expected range for a short scale given to an inpatient 
population at three intervals (see Table 2 for test-retest reliability of SA-45) 
(Maruish, 2004; SAI, 2000).  
Another way of indicating the reliability of SA-45 scores is standard 
error of measurement (SEM). SEM scores calculated for 9 subscale both 
non-clinical and inpatient samples by raw and T scores separately were 
within the acceptable range (see Table 2 for SEM scores of subscales of SA- 
45) (SAI, 2000).  
Overall the reliability of SA-45 can be regarded as psychometrically 
acceptable and that the reliability is adequate for the Symptom Assessment-
45 (SA-45) Questionnaire to be used for screening, assessment and research 
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1.3.3.3 Validity Analyses of SA-45 
Many studies were done in order to establish the validity of SA-45 
Questionnaire with different methods such as construct validity, criterion 
validity and content validity.  
For construct validity inter-scale correlations of SA-45 9 subscales 
were calculated for inpatient adult and adolescent samples. The results were 
within acceptable ranges which ranged from .38 to .75 for adults and .42 to 
.79 for adolescents (see table 3 for inter-scale correlations). 
Also the study of Davison et al. (1997) can be accepted as another 
evidence of construct validity of SA-45. In their study, two groups of 
patients who have severe depression, on all nine SA-45 symptom domain 
scales were used.  The first group consisted of 47 patients diagnosed as 
having psychotic features; the other group included the 149 patients who did 
not have these features. The results showed that patients of both groups 
scored highest on the SA-45 Depression scale; but they were not 
significantly different from each other on this measure. They had different 
scores on both Psychoticism and Phobic Anxiety scales (p <.001) where 
patients with psychotic features scored higher than patients who did not 
have these features. The effect sizes in two instances were 3.40 and 4.80, 
respectively, suggesting that these two scales may be useful in identifying 
the presence of psychotic features in depressed patients.  
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Table 4 
Correlations between SA-45 Scales and SCL-90 and BSI 
              
  Adult  Adolescent 
  SCL-90 BSI  SCL-90 BSI 
Scales   (N=1,180-1,498)  (N= 646-852)  
Anxiety  .96 .99  .96 .99 
Depression  .96 .99  .95 .99 
Hostility  .98 .96  .99 .97 
Interpersonal Sensitivity  .96 .94  .97 .94 
Obsessive Compulsive  .96 .97  .96 .97 
Paranoid Ideation  .98 1.00  .98 1.00 
Phobic Anxiety  .97 .96  .97 .96 
Psychoticism  .88 .79  .90 .81 
Somatization  .94 .90  .95 .92 
Positive Symptom Total  .98 .98  .98 .98 
Global Severity Index   .99 .99   .99 .99 
Note: Adapted from Symptom Assessment-45 Questionnaire (SA-45): Technical Manuel (p.61), by 
Strategic Advantages Inc., 2000 
 
 
For the criterion validity of SA-45 correlations were calculated 
between 11 scales and indices and SCL-90, BSI on large inpatient adult and 
adolescent samples (see table 4 for correlations between SA-45 and SCL-90 
and BSI) (Maruish, 2004; SAI, 2000).  
The results of Goldstein and Maruish’s (1997) research can be 
accepted as another evidence of criterion validity of SA-45. They 
investigated the benefits of integrative behavioral healthcare services in 
primary care settings. For this purpose, they used SA-45, SF 12 (a brief 
version of the SF-36 Health Survey which has Mental Component Summary 
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(MCS) and Physical Component Summary (PCS) subscales; Ware, Kosinski 
& Keller, 1995) and a brief self-report healthcare resource utilization 
instrument (as cited in SAI, 2000). The sample of this study consisted of 
126 adult outpatients who applied for psychological help at a family practice 
outpatient clinic. The results indicated that the SA-45 GSI (Global Severity 
Index), PST (Positive Symptom Total) indices and Somatization scale T-
scores were correlated with the SF-12 T-scores for the Mental Component 
Summary (MCS) and the Physical Component Summary (PCS) Scales. 
Correlations of the GSI with the MCS (-.69) and PCS (-.27) were both 
significant. Similarly correlations between PST and MCS (-.64) and 
between PST and PCS (-.25) were significant. Also the significant 
correlations were found between the T-scores of the SA-45 Somatization 
scale and each of MCS and PCS (-.25 and -.50 respectively) (SAI, 2000).  
The item-scale correlations of SA-45 were quite strong, generally 
between .30-.50 ranges for inpatient sample. Reynolds (1991) considers 
these numbers to be more than acceptable as far as content validity of a 
scale is concerned. Apart from these results, one may say that the items of 
each scale reflect a strong association with problem areas indicated by title 
of each scale which again implies a strong content validity. Consequently 
the item-scale correlations and symptomatology covered by each of the nine 
symptom domain scales, as well as their correlations to their SCL-90 
counterparts, attest to the SA-45’s content validity (see table 4 for 
correlations between SA-45 and SCL-90 and BSI)  (Maruish, 2004; SAI, 
2000). 
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1.4 Related Research 
As it was mentioned above SCL-90 and its revised form SCL-90-R 
was used for creating SA-45. Symptom Checklist-90 Revised (SCL-90-R), 
as a tool has always been used in academic studies, schools, and clinical 
fields to identify and assess psychological symptomology. Although SA-45 
has become a source recognized by and widely used in the foreign literature, 
it is not well known in Turkey yet. So in this part, research with related 
SCL-90-R and SA-45 are presented together. 
In the following paragraphs many studies on SCL-90-R and SA-45 
are presented. First, research which was done with SCL-90 and next, studies 
with SA-45 are reported in chronological order. 
 
1.4.1 Related Research with SCL-90-R 
SCL-90 has proved to be a very reliable and valid instrument for a 
variety of purposes. It has been used with good results in different cultures 
and contexts, with psychiatric symptomology, in assessment, screening and 
outcome research. After many years SCL-90 became a parent to SA-45. In 
the following paragraphs some of the studies done with SCL-90 are 
presented in chronological order. 
Symptom Checklist-90-Revised (SCL-90-R) was used in a study 
with patients in a psychiatry clinic. SCL-90-R was applied to 29 male and 
25 female patients aged 18-57 at Ege University Psychiatry Clinic. The 
relationships among symptom distribution, diagnosis, socio-demographic 
traits, and SCL-90-R were studied. No statistically significant differences 
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were found between average GSI scores and sub-scale scores, and diagnosis 
and socio-demographic traits (Alper, Kabaklıoğlu, Akarsu & Saygılı, 1990). 
 Validity and reliability studies of Symptom Checklist-90-Revised 
(SCL-90-R) for the Turkish university students were done by Dağ in 1991. 
The questionnaire was given to two groups of students including 99 clients 
and 532 “normal” subjects from Hacettepe University. Analysis was done to 
obtain mean, standard deviation, and score range for general indicators and 
sub scales of the questionnaire. Test-retest reliability calculations were 
carried out, internal reliability was analyzed, validity analyses with MMPI 
and Beck Depression Inventory were studied; and also the compliance of its 
theoretical aspect with empirical function structure, and the applied 
Principle Component Factor Analysis was compared. The study concluded 
that SCL-90-R is valid and reliable, and can be used on Turkish university 
students for the purpose of psychiatric assessment. However, it was 
emphasized that there was not enough evidence to prove that the 
questionnaire and its subscales could be used for clinical diagnosis beyond a 
general “distress” (GSI) level (Dağ, 1991). 
Wilson et al. (1994) studied traumatic memory/experience by using 
Post Traumatic Stress Disorder Inventory (PTSD-I), Symptom Checklist-
90-Revised (SCL-90-R) GSI (Global Severity Index) Scores, and Impact of 
Events Scale (IES) questionnaires. In the study with adults the concurrent 
validity of PTSD-I, IES and SCL-90-R GSI scores were .54 and .66. One 
week later, IES, SCL-90-RGSI scores and PTSD-I was applied again in the 
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same study, and concurrent validity was found quite high, reaching the level 
of .88 and .85   
SCL-90-R was used in a study titled “Comparison of the Social 
Phobia and Panic Disorder by means of demographic and clinical traits”. 
123 individuals participated including 72 social anxiety and 51 panic 
disorder patients. The study showed that the total scores of somatization, 
obsession, compulsion, depression, anxiety, anger/hostility, paranoid 
ideation, and psychoticism in SCL-90-R are higher in panic disorder group 
than social anxiety disorder group (p<0.05) (Gül & Dilbaz, 2003). 
In their study on the last grade high school students in Canada, 
Yang, Choe, Baity, Lee & Cho (2005) analyzed the frequency of Internet 
use and the correlation of psychiatric symptoms and personal traits. In their 
study, they analyzed the excess use of Internet by using SCL-90-R and 16PF 
profiles and it was found that the symptomology of the individuals who 
excessively use Internet are considerably high. Moreover, the study showed 
that excessive Internet users are emotionally stagnant and self sufficient 
individuals who are easily affected by emotions.   
 
1.4.2 Related Research with SA-45 
A line of research utilizing Symptom Assessment-45 Questionnaire 
(SA-45) focused on a variety of issues, samples and psychiatric symptoms 
like traumatic experience, children of divorce, psychological abuse, moral 
conflict, effect of religion on mental health and treatment outcome, along 
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with many others. In the following paragraphs many studies done with SA-
45 are presented in chronological order. 
SA-45 was used in a study with 1008 executive officers in 
Saskatchewan University in 2003. In that study, various factors and health 
conditions related to the frequency of Post Traumatic Stress Disorder in the 
population were analyzed. Post Traumatic Stress Questionnaire (PTSQ), 
Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q), 
Working Environment Scale (WES), and the Symptom Assessment 
Questionnaire (SA-45) were used. It was observed that the workers with 
significantly higher stress due to PTSD get significantly higher scores from 
five physical symptom items in SA-45 (Stadnyk, 2003). 
Rowe (2005) studied the effect of Emotional Freedom Techniques 
(EFT) workshop on psychological symptoms. 102 participants were tested 
with SA-45 on five occasions: A month before and at the beginning of the 
workshop, by the end of the workshop, one month and 6 months after the 
workshop. There was a statistically significant decrease in all measures of 
psychological symptoms as measured by SA-45.  
Chan, Hess, Whelton and Young (2005) examined if there was any 
connection between psychological trauma, shame and psychiatric symptoms 
in women diagnosed with Borderline Personality Disorder (BPD). They 
used SA-45 for screening psychiatric symptoms. The subjects were 36 
women with BPD and 49 University women. They found that the type of 
trauma like sexual abuse, death of a family member or criminal assault did 
not predict the level of shame or psychiatric symptoms.  
30 
 
Standardization of SA-45 and its adaptation to Turkish for 
adolescent population was studied on 550 adolescents, by Avcu (2006) and 
validity-reliability studies were reported. Internal consistency and test-retest 
reliability coefficients were calculated for total score and each subscale. 
Internal consistency coefficients calculated with Cronbach’s Alpha method 
varied between .55 to .78 in subscales and .92 in total. Test-retest 
correlations of the questionnaire applied to 31 individuals after one week 
were between .52 and .89 (Avcu, 2006).  
For criterion validity, 30 individuals were given SA-45 and ACL 
(Adjective Checklist), Beck Depression Inventory (BDI) and State-Trait 
Anxiety Inventory (STAI), and the correlations between them were 
calculated with Pearson Product-Moment Coefficient.  Significant negative 
relationship between PST index of SA-45, and ACL’s order, ideal self, 
sensitivity, caring, and creativity sub-dimensions were found. Significant 
positive correlations ranging from .46 to .83 between the entire subscales of 
SA-45, and PST and GSI index scores were found with Beck Depression 
Inventory. Negative correlations between Depression subscale of SA-45 and 
State Anxiety subscale of STAI; significant positive relationship between 
Anxiety, Obsessive Compulsive and Paranoid Ideation subscales of SA-45 
and Trait Anxiety  subscale of STAI were reported (Avcu, 2006).  
Lopez-Stane (2006) studied long-term effects of childhood abuse. 
221 undergraduate psychology students completed the Psychological 
Maltreatment Experiences Scale (PMES) to obtain a measure of childhood 
abuse. Participants also completed a scale measuring ongoing relationships 
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(Attachment Style Questionnaire-ASQ), psychological symptoms 
(Symptom Assessment (SA-45) and traumatic experiences (Trauma 
Symptom Inventory-TSI), and the Child Experiences Questionnaire (CEQ). 
The analysis revealed that psychological maltreatment is associated with 
high levels of trauma symptoms and problems with secure attachment. 
Moreover, the individuals who had high levels of symptoms have reported 
having more rejection, high levels of threats and isolation than the 
individuals who had low levels of symptoms. In addition, individuals who 
had high levels of symptoms tended to have more problems in the family, 
dysfunctional organization of the family and poor relationship with the 
parent. The study showed that maltreatment of the child can be a serious 
problem and had strong implications the way in which some children who 
are abused tend to show more long-term problems.  
Galek, Krause, Ellison, Kudler and Flannelly (2007) studied the 
relationship between religious doubt, mental health, and aging; in a national 
sample consisted of 1629 adult Americans. Findings indicate that religious 
doubt has a negative effect on psychological well being. Analysis also 
reveals that the effect of doubt on psychological symptomology declines as 
individuals get older. The psychological symptoms were measured by SA-
45 and include the sub scales of depression, anxiety, interpersonal 
sensitivity, paranoia, hostility, and obsessive-compulsive symptoms.  
Reay (2007) studied the long-term effects of parental alienation 
syndrome (PAS). 150 individuals, ages between 18 and 35 who experienced 
divorce of the parents participated in the study. The level of psychological 
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distress was measured by the Symptom Assessment Questionnaire (SA-45). 
PAS was measured by the Parental Alienation Syndrome Questionnaire 
(PASQ) (Machuca, 2005). Two separate PASQ instruments were given to 
the participants, measuring how the mother and the father are perceived as 
inducing alienation.  The total score on the Symptom Assessment-45 
Questionnaire (SA-45) was used to assess current psychological distress. 
The study's findings showed that individuals who have experienced divorce 
in their earlier years had high scores of PAS also had high levels of 
psychological distress as measured by SA-45.  
Church (2009) examined the effect of a new exposure therapy EFT 
(Emotional Freedom Techniques), on PTSD. The sample is composed of 11 
veterans and family members coming from Iraq. Assessment was made by 
SA-45 (Symptom Assessment 45) and the PCL-M (Posttraumatic Stress 
Disorder Checklist – Military) a month before the treatment and when the 
treatment began. The scores of both SA-45 and PCL-M showed statistically 
meaningful improvements. These improvements were maintained at 90-day 
follow-up on the general symptom index, positive symptom total and the 
anxiety, somatization, phobic anxiety, and interpersonal sensitivity 
subscales of the SA-45, and on PTSD. After the treatment, the clients did 
not have the diagnosis of PTSD. Despite the size of the sample the study 
suggests that EFT can be an effective intervention.  
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1.5 The Current Study 
In the light of the information in testing and assessment literature, 
multidimensional self-report instruments such as MMPI, and SCL-90-R 
give a lot of information about a client and they assist in diagnosing and 
planning the treatment. As mentioned above, although the multidimensional 
instruments are used in routine clinical practice frequently, their application 
is difficult and limited due to the fact that the administration and scoring is 
quite time consuming. So it needs to be short and easily administered and 
scored by multidimensional self-report instruments. In parallel to this the 
most popular tendency in testing literature is the increase of the number of 
short multidimensional self-report instruments such as SA-45 in recent 
years.   
The purpose of this study is to conduct standardization of Symptom 
Assessment-45 Questionnaire (SA-45) for the adult Turkish population. For 
this purpose, the samples of the study were separated as non-clinical and 
outpatient samples and the analyses were done in three steps which include 
reliability and validity analyses for two samples separately and norm study 
for non-clinical sample by gender.  
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Chapter 2: Method 
 
2.1 Translation of Symptom Assessment-45 Questionnaire (SA-45) 
The translation of Symptom Assessment Questionnaire (SA-45) was 
done by five professionals in clinical psychology who are bilingual in 
English and Turkish and working at The Institute for Behavioral Studies 
(DBE). 
 
2.2 Sample  
In this study two different samples for reliability and validity 
analyses were used and the non-clinical sample was also used for the norm 
study.  
The first sample of this study consisted of non-clinical adults 
including university students and professionals in companies. The size of 
the non-clinical sample was 620 individuals (441 women and 179 men) with 
mean age of 29.77 (SD=9.24; range=19-71). 520 professionals among the 
non-clinical sample of 620 individuals were working in companies.  The 
other 100 individuals were psychology students who were taking 
psychology courses at Istanbul Bilgi University.  
The second sample of this study was 2481 individuals (1588 women 
and 893 men) with a mean age of 33.35 (SD= 9.11; range=18-73) who had 
consulted Institute for Behavioral Studies (DBE) for psychotherapy.  Out of 
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2550 individuals, 69 tests were eliminated because of missing information 
so that this outpatient sample consisted of 2481 individuals.  
 
2.3 Instruments  
2.3.1 Symptom Assessment-45 (SA-45) Questionnaire 
The original Symptom Assessment-45 Questionnaire (SA-45) 
derived from the SCL-90, was translated to Turkish by 5 bilinguals who are 
professionals in clinical psychology and speak fluently and comprehend 
both languages; English and Turkish. The Turkish version of SA-45 consists 
of 45 items as well as the original (see Appendix B).  
 
2.3.2 Beck Depression Inventory 
Beck Depression Inventory was developed by Beck in 1961 and it 
was revised in 1972 (see Appendix C).  BDI includes 21 items where items 
1 to 13 measure the depressive mood and items 14 to 21 physical symptoms. 
The number written next to each item (0-3) indicates the sum of the points 
given (Beck, 1961; Savaşır & Şahin, 1997).  
Meta-analysis of 25 studies on the BDI demonstrated that the 
Cronbach’s alpha coefficients ranged between .73 and .95. Another 
reliability analysis consisted of test-retest correlations for both clinical and 
non-clinical samples. The test-retest correlations were found between .60 
and .83 for non-clinical sample. For clinical samples, the test-retest 
correlations  ranged .48 to .86. (Savaşır & Şahin, 1997). 
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Meta-analysis of at least 35 studies suggested the concurrent validty 
of BDI. In these studies correlation between BDI and the other depression 
scales such as Hamilton Depression Scale, and the Depression subscale of 
Minnesota Multiphasic Inventory ranged from .65 to .67. In another validity 
analysis of Beck Depression Inventory (BDI), scores of BDI and DSM-III 
were compared and the correlations were found between the .33 and .96. in 
psychiatric patients (Savaşır & Şahin, 1997). 
There are 2 Turkish adaptations of Beck Depression Inventory and 
the first study was done by Tegin in 1980.  In the present study, the second 
adaptation of BDI which was standardized by Hisli (1988, 1989) is used.  
For the second Turkish adaptation of BDI, the internal consistency 
which was calculated by split half method was found .74 and the test-retest 
correlations were reported to be .65 (Hisli, 1989). 
There were many studies demostrating the validity of BDI. One of 
them includes comparing scores of BDI and MMPI-D (Depression) scale. 
The study was done on 63 psychiatric patients and the correlation between 
BDI and Depression scale of MMPI was found to be .63 (Hisli, 1988). 
Another study indicating criterion validty was done by Şahin & Şahin 
(1992) on 1399 students. There were found significant correlalations 
between BDI and MMPI-D scale (r=.47),  BDI and STAI (State-Trait 
Anxiety Inventory) (r=.55) and BDI and ATQ (Automatic Thoughts 
Questionarre) (r=.74) in this study.  
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2.3.3 State-Trait Anxiety Inventory 
The State-Trait Anxiety Inventory (STAI; Spielberger, Gorsuch & 
Lushene, 1970) is a self-report instrument which includes separate measures 
of state and trait anxiety (see Appendix D).  
This inventory consists of 40 items and two subscales which are state 
anxiety and trait anxiety. The State Anxiety subscale contains 20 items that 
ask people to indicate how they feel at particular moment in time. The trait 
anxiety subscale includes 20 items that ask people to describe how they 
generally feel (Spielberger, Gorsuch & Lushene, 1970; Öner, 1997)).  
The reliability analysis of the original STAI includes internal 
consistency and test-retest reliability. The Cronbach’s alpha coefficients are 
between .83 and .92 for state anxiety and between .86 and .92 for trait 
anxiety. The test-retest reliability of trait anxiety is  between .73 and .86 and 
for state anxiety between .16 and .54 (Spielberger, Gorsuch & Lushene, 
1970; Öner, 1997).  
Le Compte and Öner’s (1985) adaptation of STAI in Turkey shows 
high degrees of internal consistency according to Cronbach’s alpha 
coefficients which are between .94 and .96 for state anxiety scale and .83 
and .87 for trait anxiety scale. The test-retest reliability for trait anxiety 
scale is between .71 and .86, for state anxiety is between .26 and .68. For the 
STAI’s construct validity study, applications with intervals varying from  10 
days to 1 year, significant correlations were found between the trait and 
state anxiety scores (r=.62, p<.01) (Öner, 1997).  
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2.4 Procedure 
In the present study, two different samples were used: clinical 
(outpatient) and non-clinical. So the procedure of the study is presented in 
two parts below.  
 
2.4.1 Procedure of Non-clinical Sample 
The non-clinical sample consisted of 620 subjects including 
university students and professionals in companies.  
• 520 subjects in the non-clinical sample who were working as 
professionals in companies were given SA-45 online.  
 30 of them were given SA-45 one week later for test-retest 
reliability analysis. 
• 100 subjects among non-clinical sample of 620 subjects were 
psychology students who are taking PSY 331 and PSY 401 courses 
at Istanbul Bilgi University.  
 20 Psychology students who are taking PSY 331 course 
joined the applications which 4 of them were not considered 
valid because of missing information. 16 of these students 
were given SA-45, Beck Depression Scale and STAI at the 
same time in the first week and one week later only SA-45 
was given to the 10 of the students. Thus, these students 
constituted 10 of the test- retest data of 40 individuals and 16 
of them for criterion validity of SA-45 and at the same time 
39 
 
Beck Depression Inventory and State-Trait Anxiety 
Inventory data of 100 individuals. 
 SA-45, Beck Depression and STAI were applied online to 84 
Psychology students who were taking PSY 401 course. The 
individuals were given ID numbers together with their school 
numbers so that students could take tests online without using 
their names.  
 
2.4.2 Procedure of Clinical Sample 
The clinical sample consisted of 2481 outpatients who applied to 
Institute for Behavioral Studies (DBE) for psychotherapy. Before the first 
session, these individuals were given SA-45. 
• Out of these 2481 subjects, 293 of them were given Beck Depression 
Inventory and State-Trait Anxiety Inventory when they arrived for 
their first session. 
 In addition, on the phone, 40 individuals, who called Institute 
for Behavioral Studies (DBE) to take an appointment for 
psychological counseling, were told that an inventory would 
be sent to them for research purposes, and were given an 
appointment for one week later. SA-45 was given online at 
the first application, then one week later when individuals 
arrived for the first session SA-45 was given again before the 
session.  
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Chapter 3: Results 
 
In this part, the psychometric analyses of SA-45 are presented. The 
results are reported in three steps. Firstly the norm calculation of SA-45 
scales was done for non-clinical sample by gender. Secondly, the reliability 
analyses were examined for both non-clinical and outpatient samples. And 
lastly, the validity analyses were executed for both non-clinical and 
outpatient samples.  
 
3.1 Norm Study 
The norm study of Turkish standardization of SA-45 for adults 
included three steps: Firstly, the mean difference of SA-45 scales between 
non-clinical and outpatient samples were calculated. Secondly, the 
influences of gender on SA-45 scales were examined. And lastly, the norm 
calculations were done which derived from SA-45 raw scores by gender on 
non-clinical sample.  
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3.1.1 Mean Differences of SA-45 Scales Between Non-clinical 
and Outpatient Samples  
In the present study, data were collected from two different 
populations, non-clinical individuals and outpatients. Before the norm 
calculations, the first step is to compare the mean scores of non-clinical and 
outpatient samples. Table 5 shows the results of independent sample t test of 
all subscales and indices of SA-45 between non-clinical and outpatient 
samples.  
 
Table 5 
T-test Results for SA-45 Subscales and Indices, Non-clinical and Outpatient 
Samples 
         
Scales   
Mean scores 
of      
 Non-clinical 
Sample          
(N=620)   
Mean scores 
of    
Outpatient 
Sample   
(N=2481)   t   p 
         
Anxiety  
8.36  11.13  -14.50  
.000** 
Depression  9.68  13.12  -17.50  .000** 
Obsessive-Compulsive  
10.01  11.36  -7.43  
.000** 
Somatization  8.43  9.65  -6.36  .000** 
Phobic Anxiety  
6.35  7.01  -4.90  
.000** 
Hostility  8.02  9.61  -8.51  .000** 
Interpersonal Sensitivity  
8.46  9.62  -6.69  
.000** 
Paranoid Ideation  9.61  10.12  -3.06  .002* 
Psychoticism  
7.28  7.54  -2.05  
.040 
Positive Symptom Total  19.45  22.67  -7.50  .000** 
Global Severity Index  
76.24  89.18  -11.22  
.000** 
                  
Using Bonferroni's correction alpha level were set at 0.004* and 0.001**. 
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The results indicated that means of all subscales and indices of SA-
45 were significantly different between non-clinical and outpatient samples. 
With the mean scores of SA-45 subscales and indices were higher for 
outpatient samples than the non-clinical samples, as presented in Table 5. 
When Bonferroni’s improvement was applied, using an alpha level of .004, 
only the Psychoticism subscale failed to show a significant difference 
between the non-clinical and outpatient samples. The results can be 
interpreted as SA-45 can differentiate between the clinical and non-clinical 
sample.    
 
3.1.2 Influence of Gender on Raw Sa-45 Scores 
Raw SA-45 scores of males and females in the non-clinical sample 
were compared using independent-sample t-test. These results indicated that 
four subscales, namely anxiety, somatization, phobic anxiety and 
psychoticism subscales were significantly different by gender. According to 
these results, women’s scores were higher than men’s on anxiety, 
somatization and phobic anxiety subscales, while men scored higher than 
women on the psychoticism scale. On the other hand, when Bonferroni’s 
improvement was applied, using an alpha level of .004, only the Anxiety 
subscale showed a significant difference between men and women (see 
Table 6 for the means and standard deviations). 
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Raw SA-45 scores of males and females in the outpatient sample 
were compared using independent-sample t-test. The results indicated that, 
except for psychoticism and hostility scales, all subscales and GSI and PST 
indices showed a significant effect of gender. The analysis indicated that 
women scored higher than men on all significant subscales and indices. On 
the other hand, when Bonferroni’s improvement was applied, using an alpha 
level of .004, only the Anxiety, Depression, Somatization subscales and 
PST and GSI indices showed a significant difference between men and 
women (see Table 7 for the means and standard deviations). 
Although not all subscales and indices revealed significant effects of 
gender in the normative (i.e., non-clinical) data, it was concluded that 
Turkish SA-45 norms should be standardized for men and women 
separately as in the original sample. Also it was found that the effect of 
gender was considerable in the outpatient sample in this study. 
 
3.1.3 Calculation of Norms 
Norm calculations were computed for all SA-45 subscales and 
indices from the raw score data acquired from the non-clinical sample 
according to gender, as was done in the original study (SAI, 2000). T scores 
were derived to have a mean of 50 and a standard deviation of 10. 
Percentiles and T scores were calculated for all of SA-45 subscales and 
indices by gender as presented in Tables 8 and 9.  
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3.2 Reliability  
For the reliability analyses of SA-45 internal consistency and test-
retest correlations were calculated for both non-clinical and outpatient 
samples.   
3.2.1 Internal Consistency 
For internal consistency Cronbach’s alpha coefficients were 
calculated for all subscales of SA-45 for both non-clinical and outpatient 
samples. For the non-clinical sample Cronbach’s alpha coefficients for the 
SA-45 subscales ranged from .58 to .83, while for the outpatient sample, 
alpha coefficients for the SA-45 subscales ranged between .63 and .82. 
Table 10 shows the Cronbach’s alpha coefficients for each SA-45 subscale 
for both sample groups defined in the present study, as well as the non-
clinical and inpatient groups used in the original study.  
For both non-clinical and outpatient samples, Psychoticism was 
found to be the subscale with lowest and inadequate internal reliability with 
.58 and .63 respectively. Similarly, for both sample groups, Anxiety, 
Depression, Hostility and Somatization subscales were found to have good 
reliability, equal to or higher than .80. Also the internal reliabilities of 
Interpersonal Sensitivity, Obsessive-Compulsive, Paranoid Ideation and 
Phobic Anxiety subscales were found marginally acceptable which means 
equal to or higher than .70 in both groups.   
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Table 10 
Internal Consistency of SA-45 Subscales 
       
    Sample in Our Study   Sample in Original Study 
 Non-clinical Outpatient  Non-clinical Inpatient 
 (N=620) (N=2481)  (N=1077-1085) (N=1471-1498) 
    Α  Α 
       
ANX  .80 .80  .74 .86 
DEP  .81 .82  .87 .91 
HOS  .83 .82  .85 .86 
INT  .78 .78  .85 .86 
OC  .71 .74  .81 .88 
PAR  .72 .70  .78 .78 
PHO  .73 .76  .82 .85 
PSY  .58 .63  .74 .73 
SOM  .83 .82  .80 .85 
              
 
 
 
3.2.2 Test-Retest Correlations 
The test-retest correlations over a one-week interval were calculated 
for both non-clinical and outpatient samples for 9 subscales and 2 indices of 
SA-45. For the non-clinical sample (N=40) test-retest correlations ranged 
from between .67 and .92. For the outpatient sample (N=40) correlations 
ranged from .44 to .87. Table 11 demonstrates the test-retest correlations for 
both samples by raw and T scores separately, together with the results of the 
original study.  
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3.3 Validity 
Validity of the SA-45 Turkish version was examined using three 
approaches: construct validity, criterion validity and content validity. 
 
3.3.1 Construct Validity 
In the present study construct validity was approached in two ways: 
first inter-correlations among the SA-45 subscales were examined and 
second, the differences between the non-clinical and outpatient samples 
were examined. 
 
 
Table 12 
Correlation between SA-45 Scales for the Non-clinical Sample 
(N=620) 
          
  ANX DEP HOS INT OC PAR PHO PSY SOM 
ANX  .76** .60** .66** .66** .57** .51** .46** .60** 
DEP   .61** .71** .65** .57** .44** .47** .55** 
HOS    .59** .55** .58** .41** .48** .52** 
INT     .64** .70** .47** .57** .46** 
OC      .55** .37** .46** .51** 
PAR       .47** .54** .44** 
PHO        .31** .43** 
PSY                 .34** 
* p<.05, ** p<.01 
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Anastasi (1982, p.144) has stated “the construct validity of a test is 
the extent to which the test may be said to measure a theoretical construct 
or trait”. Following this statement, one way to measure construct validity of 
multidimensional instruments can be examined the degree of independence 
of the subscales of the instrument from each other. The levels of the 
independence of the scales indicate the extent of the correlations of the 
subscales with each other (SAI, 2000). In the case of a scale like the SA-45, 
a pattern of inter-correlations showing both similarities and differences 
among subscales is to be expected.  
 
 
 
 
 
Table 13 
Correlation between SA-45 Scales for the Outpatient Sample 
(N=2481) 
          
  ANX DEP HOS INT OC PAR PHO PSY SOM 
ANX  .62** .47** .53** .56** .47** .60** .48** .59** 
DEP   .45** .59** .56** .48** .33** .44** .46** 
HOS    .46** .43** .55** .28** .41** .42** 
INT     .60** .68** .45** .57** .41** 
OC      .51** .40** .49** .50** 
PAR       .36** .54** .42** 
PHO        .41** .45** 
PSY                 .35** 
* p<.05 ,**p<.01     
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The inter-scale correlations were calculated for both non-clinical and 
outpatient samples. The results indicated that SA-45 subscales were 
significantly inter-correlated in both non-clinical and outpatient samples, as 
presented in Tables 12 and 13. 
The differences between the scores of SA-45 subscales between non-
clinical and outpatient samples can be accepted as another type of evidence 
construct validity.  As presented in Table 5, there were significant 
differences between non-clinical and outpatient samples regarding all of the 
subscales and indices of SA-45 except for Psychoticism scale. The mean 
scores of outpatient sample were higher than the non-clinical sample’s mean 
scores on all the SA-45 subscales. Also while comparing the mean scores of 
outpatient sample in our study and mean scores of inpatient sample in the 
original study, it is seen that the mean scores of inpatient sample were 
higher than mean scores of outpatient sample in all SA-45 scales.  
 
3.3.2 Criterion Validity  
To determine the criterion validity, the correlations between 
subscales of SA-45 and scores of Beck Depression Inventory and State-Trait 
Anxiety Inventory were calculated for both non-clinical and outpatient 
samples.  
Positive moderate correlations are expected between SA-45 scales 
and scores of Beck Depression Inventory and State-Trait Anxiety Inventory. 
Particularly, high correlations are expected between SA-45 Depression 
subscale and Beck Depression Inventory. Similarly, high correlations are 
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expected between SA-45 Anxiety Scale and scores of State-Trait Anxiety 
Inventory. Examination of Tables 14 and 15 shows that the data closely 
follow this expected pattern. 
 
 
Table 14 
Correlations between SA-45 Scales and Beck Depression 
Inventory 
     
    Beck Depression Inventory 
  
Non-clinical 
Sample  
Outpatient 
Sample 
Subscales and Indices  (N=100)  (N=293) 
     
Anxiety  .71***  .66*** 
Depression  .75***  .79*** 
Hostility  .59***  .55*** 
Interpersonal Sensitivity  .69***  .53*** 
Obsessive-Compulsive  .39***  .38*** 
Paranoid Ideation  .48***  .49*** 
Phobic Anxiety  .55***  .52*** 
Psychoticism  .40***  .48*** 
Somatization  .53***  .26*** 
Positive Symptom Total  .60***  .61*** 
Global Severity Index  .71***  .73*** 
          
* p<.05, **p<.01, *** p<.001 
 
 
The results demonstrated that there were significant correlations 
between SA-45 subscales and indices and scores of Beck Depression 
Inventory for both non-clinical and outpatient samples, as presented in the 
Table 14. 
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Table 15 
Correlations between SA-45 Scales and State-Trait Inventory Scales 
         
    Non-clinical Sample   Outpatient Sample 
  (N=100)  (N=293) 
Subscales 
and Indices   
State 
Anxiety 
Trait 
Anxiety 
General 
Anxiety   
State 
Anxiety 
Trait 
Anxiety 
General 
Anxiety 
         
ANX  .69*** .64*** .78***  .56*** .54*** .67*** 
DEP  .68*** .66*** .79***  .52*** .57*** .66*** 
HOS  .40*** .68*** .61***  .38*** .54*** .55*** 
INT  .55*** .50*** .62***  .37*** .46*** .50*** 
OC  .29** .46*** .43***  .31*** .38*** .41*** 
PAR  .43*** .43*** .50***  .31*** .43*** .44*** 
PHO  .31*** .59*** .50***  .35*** .65*** .60*** 
PSY  .25* .57*** .45***  .23*** .56*** .48*** 
SOM  .38*** .44*** .47***  .15** .32*** .28*** 
PST  .47*** .62*** .62***  .57*** .56*** .68*** 
GSI  .57*** .69*** .73***  .51*** .68*** .72*** 
                  
* p<.05, ** p<.01, *** p<.001 
 
 
Similarly, the results indicated that sub-scores which included state 
anxiety and trait anxiety and total scores of State-Trait Anxiety Inventory 
correlated with subscales and indices of SA-45 significantly, as presented in 
the Table 15. 
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Table 16 
Item-scale Correlations of SA-45 for Non-clinical Sample (N=620) 
           
Scales 
Item 
No ANX DEP HOS INT OC PAR PHO PSY SOM 
 S4 .74 .52 .31 .42 .44 .36 .35 .31 .36 
 S10 .75 .51 .42 .49 .46 .41 .48 .33 .40 
ANX S30 .82 .69 .54 .58 .62 .47 .37 .34 .56 
 S38 .68 .54 .43 .45 .38 .39 .49 .33 .43 
 S41 .74 .61 .52 .52 .54 .48 .25 .40 .46 
 S1 .58 .77 .44 .55 .49 .44 .30 .35 .37 
 S2 .63 .81 .46 .51 .51 .43 .34 .36 .48 
DEP S3 .50 .72 .44 .42 .41 .39 .30 .31 .41 
 S27 .51 .72 .44 .52 .51 .40 .34 .31 .38 
 S42 .62 .72 .51 .67 .54 .48 .36 .44 .41 
 S11 .59 .56 .81 .53 .52 .53 .37 .40 .47 
 S34 .38 .39 .76 .42 .39 .43 .22 .39 .38 
HOS S35 .45 .49 .81 .47 .42 .44 .28 .36 .42 
 S39 .42 .40 .68 .42 .37 .41 .35 .34 .35 
 S43 .43 .47 .79 .42 .4 .41 .32 .34 .36 
 S14 .51 .61 .50 .71 .50 .58 .34 .42 .39 
 S15 .42 .43 .37 .71 .38 .51 .32 .37 .29 
INT S17 .43 .46 .30 .66 .44 .35 .28 .39 .21 
 S32 .53 .53 .48 .77 .48 .55 .42 .43 .42 
 S36 .50 .53 .45 .79 .49 .52 .35 .46 .31 
 S16 .24 .22 .15 .25 .61 .27 .11 .21 .08 
 S20 .30 .25 .22 .3 .60 .32 .22 .30 .23 
OC S21 .55 .52 .42 .53 .75 .4 .27 .35 .31 
 S25 .55 .52 .52 .48 .65 .42 .33 .37 .57 
 S28 .60 .65 .52 .55 .74 .42 .28 .32 .50 
 S6 .34 .42 .37 .42 .33 .59 .32 .27 .26 
 S9 .38 .37 .38 .46 .38 .72 .31 .31 .24 
PAR S19 .42 .39 .42 .49 .43 .66 .38 .47 .39 
 S40 .37 .40 .40 .45 .34 .68 .28 .38 .31 
 S44 .42 .40 .42 .56 .39 .77 .33 .43 .31 
 S7 .27 .22 .26 .26 .22 .29 .70 .13 .22 
 S12 .27 .26 .24 .27 .17 .33 .66 .28 .21 
PHO S22 .32 .29 .21 .22 .21 .24 .70 .13 .31 
 S24 .52 .39 .40 .46 .40 .42 .76 .31 .41 
 S37 .32 .32 .24 .37 .22 .32 .67 .23 .30 
 S5 .14 .17 .20 .25 .15 .31 .12 .69 .09 
 S8 .34 .31 .25 .28 .27 .26 .27 .44 .28 
PSY S13 .28 .29 .30 .35 .29 .36 .16 .65 .17 
 S33 .45 .46 .47 .59 .44 .45 .29 .69 .32 
 S45 .24 .27 .28 .29 .30 .26 .16 .55 .23 
 S18 .31 .30 .28 .23 .31 .26 .25 .12 .75 
 S23 .49 .42 .35 .37 .36 .36 .41 .29 .62 
SOM S26 .45 .43 .47 .37 .37 .34 .38 .34 .76 
 S29 .55 .50 .45 .43 .49 .37 .28 .30 .84 
  S31 .51 .47 .47 .38 .42 .37 .34 .26 .87 
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Table 17 
Item-scale Correlations of SA-45 for Outpatient Sample (N=2,481) 
           
Scales 
Item 
No ANX DEP HOS INT OC PAR PHO PSY SOM 
 S4 .76 .51 .25 .37 .35 .28 .43 .33 .35 
 S10 .76 .31 .30 .36 .36 .33 .54 .38 .42 
ANX S30 .77 .59 .45 .46 .53 .42 .37 .34 .52 
 S38 .73 .30 .27 .33 .34 .29 .59 .32 .47 
 S41 .72 .55 .46 .43 .49 .44 .32 .41 .46 
 S1 .41 .75 .31 .44 .35 .36 .21 .30 .30 
 S2 .48 .77 .30 .35 .39 .32 .20 .29 .33 
DEP S3 .46 .77 .32 .36 .41 .32 .25 .30 .36 
 S27 .54 .79 .39 .47 .51 .39 .33 .37 .44 
 S42 .46 .73 .38 .61 .47 .45 .27 .42 .33 
 S11 .41 .40 .79 .37 .36 .45 .21 .32 .35 
 S34 .30 .29 .74 .32 .29 .39 .22 .33 .30 
HOS S35 .38 .38 .79 .37 .37 .41 .24 .35 .35 
 S39 .36 .31 .69 .38 .33 .45 .22 .30 .28 
 S43 .33 .31 .80 .31 .30 .38 .18 .27 .31 
 S14 .39 .49 .45 .69 .42 .56 .25 .38 .35 
 S15 .34 .39 .33 .73 .40 .56 .32 .45 .29 
INT S17 .35 .48 .24 .70 .44 .38 .33 .41 .24 
 S32 .42 .39 .33 .78 .46 .51 .41 .42 .37 
 S36 .42 .41 .32 .78 .48 .49 .35 .43 .27 
 S16 .23 .26 .19 .36 .66 .29 .21 .27 .21 
 S20 .31 .24 .26 .36 .66 .36 .26 .32 .27 
OC S21 .44 .47 .32 .47 .75 .37 .28 .36 .30 
 S25 .43 .47 .37 .42 .66 .38 .33 .38 .50 
 S28 .52 .55 .36 .47 .75 .37 .31 .37 .45 
 S6 .26 .32 .35 .35 .25 .60 .20 .31 .20 
 S9 .38 .35 .40 .44 .36 .72 .28 .32 .32 
PAR S19 .38 .31 .35 .57 .42 .68 .37 .48 .36 
 S40 .26 .31 .31 .45 .30 .62 .18 .32 .24 
 S44 .32 .35 .42 .50 .39 .75 .25 .42 .30 
 S7 .43 .23 .19 .32 .28 .28 .73 .34 .31 
 S12 .37 .20 .16 .25 .22 .21 .66 .28 .25 
PHO S22 .39 .18 .18 .21 .21 .21 .73 .21 .31 
 S24 .50 .26 .19 .40 .37 .30 .75 .32 .36 
 S37 .44 .31 .27 .42 .33 .33 .76 .35 .38 
 S5 .31 .33 .24 .39 .31 .41 .24 .73 .20 
 S8 .27 .15 .19 .19 .19 .21 .27 .43 .22 
PSY S13 .27 .25 .21 .38 .31 .38 .25 .67 .70 
 S33 .39 .36 .36 .45 .42 .39 .30 .71 .32 
 S45 .29 .27 .30 .34 .30 .31 .28 .61 .24 
 S18 .31 .26 .25 .23 .28 .26 .22 .17 .72 
 S23 .47 .28 .31 .27 .36 .27 .40 .24 .65 
SOM S26 .46 .35 .32 .30 .38 .31 .39 .32 .77 
 S29 .54 .46 .36 .39 .47 .37 .37 .32 .83 
  S31 .49 .43 .35 .38 .43 .37 .35 .31 .84 
58 
 
3.3.3 Content Validity 
As Reynolds (1991) indicated, the content validity is examined with 
item-scale correlations. In the original study of SA-45, item-scale 
correlations were calculated for inpatient adult and adolescent samples and 
the results were accepted as an evidence of content validity of SA-45.  
In the present study the item-scale correlations ranged from .44 to 
.87 between the each item and each subscale in the non-clinical sample, as 
shown Table 16. The item-scale correlations were between .43 and .84 
between the each item and each subscale for the outpatient sample, as 
presented in Table 17. The strong correlations between items and subscales 
of SA-45 suggested high content validity of SA-45 in both non-clinical and 
outpatient samples.   
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Chapter 4: Discussion 
 
The purpose of this study was to standardize the SA-45 for the 
Turkish adult population. For this purpose, reliability and validity analyses 
were carried out for both non-clinical and outpatient samples, and a norm 
study was performed on the standardization sample.  
The non-clinical sample consisted of 100 university students and 520 
employees in various companies. Unlike the original study, the clinical 
sample did not include inpatients, but rather 2481 outpatients who had 
applied to the Institute for Behavioral Studies (DBE) for psychotherapy.  
The standardization of SA-45 was conducted in three steps. First, the 
norm study of SA-45 scales was performed for the non-clinical sample by 
gender. Second, the reliability analyses were conducted for both non-clinical 
and outpatient sample. And finally, the validity analyses were performed for 
both non-clinical and outpatient samples.  
The first step of the norm study was the comparison of non-clinical 
and outpatient samples. The results demonstrated that all of the subscales 
and indices of SA-45 mean scores of the outpatient sample were 
significantly higher than those of the non-clinical sample (p<.001 for all 
subscales, except for Paranoid Ideation – p=.002 – and for Psychoticism – 
p=.040 - see Table 5). When Bonferroni’s improvement was applied, using 
an alpha level of .004, only the Psychoticism subscale failed to show a 
60 
 
significant difference between the non-clinical and outpatient samples. 
Consequently the results supported the use of the SA-45 to screen for 
symptoms of psychological disorder. In addition, if the current study had 
included an inpatient instead of an outpatient sample, we might assume that 
between-group differences could have been higher. 
Secondly, the influence of gender on SA-45 subscales and indices 
was examined for both non-clinical and outpatient samples. The results 
indicated that Anxiety, Somatization, Phobic Anxiety, and Psychoticism 
subscales were significantly affected by gender for the non-clinical sample. 
While women’s scores were higher than those of men on Anxiety, 
Somatization, and Phobic Anxiety subscales; on the Psychoticism subscale, 
men scored higher than women in the non-clinical sample. On the other 
hand, when Bonferroni’s improvement was applied, using an alpha level of 
.004, only the Anxiety subscale showed a significant difference between 
men and women in the non-clinical sample. While women scored 
significantly higher than men on all subscales and indices except for 
Psychoticism and Hostility subscales, when Bonferroni’s improvement was 
applied, using an alpha level of .004, only the Anxiety, Depression, 
Somatization subscales and PST and GSI indices showed a significant 
difference between men and women in the outpatient sample. 
Although not for all subscales, the effect of gender was robust in our 
samples; and thus, it was concluded that Turkish SA-45 norms should be 
standardized for men and women separately as in the original sample.  
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And as the last step of the norm study, following the procedure used 
by the original study, percentiles and T scores were calculated by gender for 
all SA-45 subscales and indices from the raw score data which was gathered 
from the non-clinical sample. T scores were derived to have a mean of 50 
and a standard deviation of 10. It was shown that percentiles and T scores of 
SA-45 subscales and indices were relatively similar for both current and 
original studies for the non-clinical samples by gender.  
In the original study, as a general rule T scores of 60 or higher are 
accepted as a cutoff point indicating a possible clinical significance which 
requires further investigation. Furthermore, 65 or 70 T score is accepted as 
the criterion, score for non referred individuals who were not identified as 
having psychological problems (SAI, 2000). These general rules of the 
original study for making a clinical decision are also acceptable for this 
study.  
The reliability analyses of the current study included internal 
consistency and test-retest correlations. 
For internal consistency, Cronbach’s alpha coefficients were 
calculated for all subscales of SA-45 for both non-clinical and outpatient 
samples. For the non-clinical sample Cronbach’s alpha coefficients of the 
SA-45 subscales ranged between .71 and .83 except for the Psychoticism 
scale (α= .58). Similarly in the original study for the non-clinical sample, 
the Cronbach’s alpha coefficients were found between .74 and .87. Both in 
the present and original studies, the lowest alpha coefficients were found for 
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the Psychoticism scale (α=.58 and .74, respectively) but in the original study 
the coefficient was higher than the present study.  
For the outpatient sample, alpha coefficients of SA-45 subscales 
were between .63 and .82 where the highest coefficient belonged to 
Hostility and Somatization scales and the Psychoticism scale had the lowest 
coefficient as in the non-clinical sample. In the original study, the clinical 
sample consisted of inpatients for which alpha coefficients were reported 
between .73 and .91. Similarly, the lowest coefficient belonged to the 
Psychoticism scale in the original study.  
Results for the internal consistency analyses indicate that the Turkish 
version of SA-45 has reasonable levels of internal consistency overall. 
However, relatively lower levels of internal consistency for the 
Psychoticism scale, especially for the non-clinical sample, might make it 
advisable clinicians not to heavily rely on SA-45 to screen out psychotic 
symptoms.  
In the present study the test-retest correlations were examined for 
raw and T scores of SA-45 scales separately with one week interval for the 
non-clinical sample, as in the original study. In the original study, for the 
inpatients the test-retest correlations were calculated with one-, two-, and 
three week intervals only over the raw scores. In the present study the test-
retest correlations were computed for the outpatient sample for both raw and 
T scores of SA-45 separately with one-week interval. Due to the constraints 
of the clinical setting where this study was conducted, the test-retest 
reliability study was done with one week interval. This might be regarded as 
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a weakness of the standardization study. A further study using longer test-
retest intervals might be useful to overcome this weakness.  
For the non-clinical sample (N=40) test-retest correlations of SA-45 
subscales and indices were found between .67 and .92 in the current study. 
On the other hand, in the original study, for the non-clinical adult sample 
(N=57) test-retest correlations were between .42 and .88. While in the 
present study, the lowest test-retest reliability belonged to Psychoticism 
scale (r=.67), in the original study the Psychoticism scale had the highest 
coefficient (r=.88). In the original study the lowest test-retest correlation 
coefficient belonged to Anxiety scale (r=.42) which was higher in the 
present study (r=.85). In the present study the GSI had the highest test-retest 
correlation coefficient (r=.92).  
For the outpatient sample (N=40) test-retest correlations of SA-45 
subscales and indices were found between .44 and .87 in the present study. 
While the highest test-retest correlation belonged to Interpersonal 
Sensitivity subscale, the Hostility subscale had the lowest test-retest 
correlation. Comparing outpatient test-test correlations of this study with the 
inpatient test-retest correlations of the original study; it was shown that 
generally the test-retest correlations of the present study were higher than 
the test-retest correlations of the original study. The test-retest correlations 
of inpatients were between .42 and .59 for one-week interval, .38 and .60 for 
two-week interval, and .51-.65 for three-week interval in the original study. 
Differing from the non-clinical test-retest correlations, these relatively low 
correlations of the original study were attributed by the scale authors to the 
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sample characteristics which included psychiatric inpatients who were   
emotionally unstable (SAI, 2000).   
Examining the overall results of reliability analyses of the present 
study in comparison with the original study, it can be said that generally the 
results of the present study were found to be similar to those of the original 
study, with one caveat for the Psychoticism scale mentioned above. 
Consequently, the overall results of reliability analyses were within 
acceptable levels and Turkish version of SA-45 was proved to be a reliable 
instrument.    
In the present study, several analyses were performed to examine 
different types of validity, including construct, criterion and content 
validity.  
To determine the construct validity, inter-scale correlations were 
calculated for both non-clinical and outpatient samples in the current study. 
In the original study the inter-scale correlations had been calculated only for 
the inpatient sample.  
Anastasi (1982, p.144) has stated “the construct validity of a test is 
the extent to which the test may be said to measure a theoretical construct 
or trait”. Following this statement, one way to measure construct validity of 
multidimensional instruments can be examined the degree of independence 
of the subscales of the instrument from each other. The levels of the 
independence of the scales indicate the extent of the correlations of the 
subscales with each other (SAI, 2000).  
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In the case of a scale like the SA-45, a pattern of inter-correlations 
showing both similarities and differences among subscales is to be expected. 
So the results indicated that SA-45 subscales were significantly inter-
correlated in both non-clinical and outpatient samples.  
To the extent that all the subscales tap forms of psychological 
distress, moderate positive correlations are expected.  Lower correlations 
can be expected between subscales measuring more distinct types of distress 
(e.g., Psychoticism and Phobic Anxiety for non-clinical sample), while 
higher correlations can be expected between subscales that measure more 
closely related types of distress (e.g., Anxiety and Depression for non-
clinical sample).  Examination of Tables 12 and 13 shows that the data 
closely follow this expected pattern. 
Generally the results of inter-correlations of the present study which 
were reported for the outpatient sample were similar to the results of the 
inpatient sample in the original study. While in the present study, the 
highest correlation was between the Interpersonal Sensitivity and Paranoid 
Ideation (r=68), in the original study, it was between the Interpersonal 
Sensitivity and Depression scales (r=.75). On the other hand, the lowest 
correlation in both samples was between the Hostility and Phobic Anxiety 
scales (r=.28 and r=.38, respectively).  
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In addition, to determine the construct validity, the mean scores of 
all SA-45 scales between non-clinical and outpatient samples were 
compared in the present study. Except for Psychoticism subscale, in all 
subscales and indices of SA-45, the mean scores of outpatient sample were 
significantly higher than those of the non-clinical sample.  
Consequently, the results supported the construct validity of the 
Turkish version of SA-45.  
In the original study for the criterion validity, correlation analyses 
were conducted between SA-45 scales and SCL-90, BSI and SF-12 and the 
results were found to be significant. In the present study, to demonstrate 
criterion validity correlations were calculated between the SA-45 scales and 
scores of Beck Depression Inventory and State-Trait Anxiety Inventory.  
The results indicated that there were positive moderate correlations 
between SA-45 scales and Beck Depression Inventory for both non-clinical 
and outpatient samples. Furthermore the high correlations were between 
SA-45 Depression subscale and Beck Depression Inventory for the both 
non-clinical and outpatient samples as were expected. In addition, generally 
for the non-clinical sample, the high correlations were found between SA-45 
Depression, Anxiety subscales and GSI index and scores of State-Trait 
Anxiety Inventory. Similarly, for the outpatient sample the high correlations 
were between SA-45 Anxiety and Depression subscales and PST and GSI 
indices and scores of State-Trait Anxiety Inventory.  
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Examining these results, broadly speaking, one may conclude that 
these results are highly meaningful. Namely SA-45 is an instrument 
designed for screening the symptoms of general psychological distress 
through various psychiatric symptomatology which include the scales of 
Beck Depression Inventory and State-Trait Anxiety Inventory.  
In the original study, item-scale correlations were accepted as the 
evidence of content validity. As in the original study, item-scale correlations 
were calculated for both non-clinical and outpatient samples in the present 
study, and they were found to be acceptable and supporting the content 
validity.   
Overall these results demonstrated that SA-45 is a valid and reliable 
instrument for use with the Turkish adult population and it can be used for 
several clinical purposes such as screening, helping diagnose, planning 
treatment, monitoring, and therapy outcome assessment. Furthermore, these 
results were valid for non-clinical and outpatient samples. However, further 
studies are needed with inpatient samples to complete the Turkish 
standardization of SA-45.   
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Appendix A: Symptom Assessment-45 Questionnaire (SA-45) 
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Appendix B: Turkish version of the Symptom Assessment-45 Questionnaire (SA-45) 
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Appendix C: Turkish version of the Beck Depression Inventory 
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Appendix D: Turkish version of the State-Trait Anxiety Inventory 
 
 
 
